Global Genetic Engineering Market By Product type (Cell Line , Animal Genome, Plant Genome), By Technique (Artificial Selection, Cloning, Gene Splicing, Others)By End User (Pharmaceutical companies, Biotechnology Companies, Academics, Clinical Research Organizations)By Geography  

Purchase Option

$ 4400
$ 6600
$ 8900

Genetic Engineering Market size was valued at USD 4.8 billion in 2022 and is poised to grow at a significant CAGRof 15.55% during the forecast period 2023-2029. The alteration of genes in an organism or species to improve its skills is known as genetic engineering. Pharmaceutical and biotechnology firms, as well as clinical research institutions, utilise the technology. Gene therapy is the most extensively utilised therapeutic method for cancer and other infectious disorders in medicine. Genetic engineering Market alludes to the set of technologies that directly manipulate on an organism's genes, change the genetic makeup of cells and add one or more new traits that are not found in that organism. At the core of all life is the thing that we call DNA. It is in charge of the plenitude of life on this Earth and the motivation behind why we are how we are. The hereditary make-up of any creature is characterized by DNA. In nature, the genetic nature never stays settled. Biotech and pharma sectors dominating the Genetic Engineering Market industry owing to several applications in drug discovery and therapeutics. With the increase in the use of CRISPR and ZFN, companies are capitalizing on innovative researches focusing on the development of editing techniques. For example, the introduction of an initiative called the Artemisinin Project is planning to use synthetic biology to help treat malaria. Key strategies implemented by industry players include mergers and acquisitions, strategic collaborations for R&D outsourcing or manufacturing activities are driving the market growth of genome editing.

The Genetic Engineering Market Key Developments : 
  • Thermo Fisher acquired Life technologies in 2014, to create unbeatable leadership in life sciences, research, specialty diagnostics and applied markets.

Genetic Engineering Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

15.55%

Largest Market

North America

Fastest Growing Market

Asia-Pacific
Genetic Engineering Market Dynamics

Increasing prevalence of cancer and other genetic disorders, growing preference for personalized medicine, Increase in R&D expenditure and growth of biotechnology and pharmaceutical industries, increase in private and public sector funding, rapid advancements in sequencing and genetic engineering technologies, applications in various drug discovery processes are some of the factors propelling the growth of the genetic engineering market. Moreover, Global genetic engineering market may be hindered by stringent government regulations for approval to gene mutation projects, ethical issues, unavailability of gene based therapeutics in the market and lack of awareness among people regarding the safety of genetic interventions.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018-2022) and forecast (2023-2029)
  • The report covers in-detail insights about the competitor's overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup's details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis in addition to recent technology advancements and innovations in the market

 

 

Genetic Engineering Market Segmentation

By Type
  • Cell Line
  • Animal Genome
  • Plant Genome
By Technique
  • Artificial Selection
  • Cloning
  • Gene Splicing
  • Others
By End User
  • Pharmaceutical companies
  • Biotechnology Companies
  • Academics
  • Clinical Research Organizations
By Geography

North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

Frequently Asked Questions

Increasing number of genetic disorders.

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

1.Executive Summary
2.Global Genetic Engineering Market Introduction 
2.1.Global Genetic Engineering Market  - Taxonomy
2.2.Global Genetic Engineering Market  - Definitions
2.2.1.Type
2.2.2.Technique
2.2.3.End User
2.2.4.Region
3.Global Genetic Engineering Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.Global Genetic Engineering Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.Global Genetic Engineering Market  By Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Cell Line
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Animal Genome
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Plant Genome
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
6.Global Genetic Engineering Market  By Technique, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Artificial Selection
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Cloning
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Gene Splicing
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Others
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
7.Global Genetic Engineering Market  By End User, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Pharmaceutical companies
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Biotechnology Companies
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Academics
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
7.4. Clinical Research Organizations
7.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.4.3. Market Opportunity Analysis 
8.Global Genetic Engineering Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
8.2. Europe
8.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.2.3. Market Opportunity Analysis 
8.3. Asia Pacific (APAC)
8.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.3.3. Market Opportunity Analysis 
8.4. Middle East and Africa (MEA)
8.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.4.3. Market Opportunity Analysis 
8.5. Latin America
8.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.5.3. Market Opportunity Analysis 
9.North America Genetic Engineering Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Cell Line
9.1.2.Animal Genome
9.1.3.Plant Genome
9.2.  Technique Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Artificial Selection
9.2.2.Cloning
9.2.3.Gene Splicing
9.2.4.Others
9.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Pharmaceutical companies
9.3.2.Biotechnology Companies
9.3.3.Academics
9.3.4.Clinical Research Organizations
9.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.Europe Genetic Engineering Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
10.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.1.1.Cell Line
10.1.2.Animal Genome
10.1.3.Plant Genome
10.2.  Technique Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Artificial Selection
10.2.2.Cloning
10.2.3.Gene Splicing
10.2.4.Others
10.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Pharmaceutical companies
10.3.2.Biotechnology Companies
10.3.3.Academics
10.3.4.Clinical Research Organizations
10.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.4.1.Germany
10.4.2.France
10.4.3.Italy
10.4.4.United Kingdom (UK)
10.4.5.Spain
10.4.6.Rest of EU
11.Asia Pacific (APAC) Genetic Engineering Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
11.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.1.1.Cell Line
11.1.2.Animal Genome
11.1.3.Plant Genome
11.2.  Technique Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Artificial Selection
11.2.2.Cloning
11.2.3.Gene Splicing
11.2.4.Others
11.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Pharmaceutical companies
11.3.2.Biotechnology Companies
11.3.3.Academics
11.3.4.Clinical Research Organizations
11.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.4.1.China
11.4.2.India
11.4.3.Australia and New Zealand (ANZ)
11.4.4.Japan
11.4.5.Rest of APAC
12.Middle East and Africa (MEA) Genetic Engineering Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
12.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.1.1.Cell Line
12.1.2.Animal Genome
12.1.3.Plant Genome
12.2.  Technique Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Artificial Selection
12.2.2.Cloning
12.2.3.Gene Splicing
12.2.4.Others
12.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Pharmaceutical companies
12.3.2.Biotechnology Companies
12.3.3.Academics
12.3.4.Clinical Research Organizations
12.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.4.1.GCC Countries
12.4.2.South Africa
12.4.3.Rest of MEA
13.Latin America Genetic Engineering Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
13.1. Type Analysis  and Forecast  by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.1.1.Cell Line
13.1.2.Animal Genome
13.1.3.Plant Genome
13.2.  Technique Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Artificial Selection
13.2.2.Cloning
13.2.3.Gene Splicing
13.2.4.Others
13.3.  End User Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Pharmaceutical companies
13.3.2.Biotechnology Companies
13.3.3.Academics
13.3.4.Clinical Research Organizations
13.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.4.1.Brazil
13.4.2.Mexico
13.4.3.Rest of LA
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.Thermo Fisher Scientific Inc. (US)
14.2.2.Merck KGaA (Germany)
14.2.3.Horizon Discovery Group Plc. (UK)
14.2.4.Transposagen Biopharmaceuticals Inc. (US)
14.2.5.New England Biolabs (U.S)
14.2.6.Genscript Biotech Corporation (US)
14.2.7.Lonza Group Ltd. (Switzerland)
14.2.8.Origene Technologies, Inc. (US)
14.2.9.Integrated DNA Technologies, Inc. (US)
14.2.10.Amgen Inc.(US)
14.2.11.Genentech, Inc. (US)
14.2.12.Sangamo Therapeutics, Inc. (US)
15. Research Methodology 
16. Appendix and Abbreviations 
  • Thermo Fisher Scientific Inc. (US)
  • Merck KGaA (Germany)
  • Horizon Discovery Group Plc. (UK)
  • Transposagen Biopharmaceuticals Inc. (US)
  • New England Biolabs (U.S)
  • Genscript Biotech Corporation (US)
  • Lonza Group Ltd. (Switzerland)
  • Origene Technologies, Inc. (US)
  • Integrated DNA Technologies, Inc. (US)
  • Amgen Inc.(US)
  • Genentech, Inc. (US)
  • Sangamo Therapeutics, Inc. (US)

Adjacent Markets